US 9260500
Peptide and use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 9260500 (Peptide and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61P, A61P3/04, A61P43/00